Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19
N Engl J Med
.
2024 Apr 25;390(16):1533-1534.
doi: 10.1056/NEJMc2402378.
Authors
Carlee B Moser
1
,
Jonathan Z Li
2
,
Michael D Hughes
3
Affiliations
1
Harvard T.H. Chan School of Public Health, Boston, MA cmoser@sdac.harvard.edu.
2
Harvard Medical School, Boston, MA.
3
Harvard T.H. Chan School of Public Health, Boston, MA.
PMID:
38657253
DOI:
10.1056/NEJMc2402378
No abstract available
Publication types
Letter
Comment
MeSH terms
Administration, Oral
Adult
Aged
Antiviral Agents* / administration & dosage
Antiviral Agents* / therapeutic use
COVID-19 Drug Treatment*
COVID-19* / therapy
Female
Humans
Male
Middle Aged
SARS-CoV-2
Viral Load
Substances
Antiviral Agents